FDA Inspection
Charles River Laboratories, Inc.Charles River Laboratories, Inc. – FDA Inspection, Jan 13, 2017
Record Details
This FDA Inspection record concerns Charles River Laboratories, Inc., with an inspection on January 13, 2017, issued by the San Francisco District Office, covering human drugs.
- People
- Amanda Lewin (Issuing Officer)
- Kara A. Scheibner (Company Rep)
- Thea C. Grome (Company Rep)
- Xiaohan Cai (Company Rep)
View Company Profile
ID · c3d490be-3aba-4b84-a30f-fa6efadd371d
Inspection Facts
- Inspection number
- 1003239
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Charles River Laboratories, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2025 | VAI | San Francisco District Office | Bioresearch Monitoring: Human Drugs |
| June 15, 2018 | VAI | San Francisco District Office | Bioresearch Monitoring |
| May 26, 2017 | Not classified | San Francisco District Office |
Other documents for Charles River Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.